UK suing Servier over alleged generic blocking

June 7, 2011
Sales and Marketing Peridopril, Servier, generics

The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …

Bayer submits Lucentis rival for European approval

June 7, 2011
Sales and Marketing Bayer, Lucentis, Regeneron, VEGF Trap-Eye

Bayer Healthcare has submitted its new eye drug to European regulators for approval to treat age-related macular degeneration (wet AMD). …

Merck plans cancer drug submissions later this year

June 7, 2011
Research and Development, Sales and Marketing Merck & Co, ridaforolimus

Merck & Co is to submit its oral investigational cancer drug ridaforolimus to European and US regulators later this year …

European falsified meds directive: implications for manufacturers

June 7, 2011
Manufacturing and Production APIs, GDP, GMP, excipients, pharma manufacturing

The Council of the European Union gave its backing to the new Directive on Falsified Medicines on May 27, setting …

Merck Serono headquarters

Erbitux meets gold standard in rectal cancer

June 7, 2011
Research and Development, Sales and Marketing Erbitux, Merck Serono, rectal cancer

Studies of Merck Serono’s Erbitux in rectal cancer have shown improved overall survival, a gold standard measure in oncology trials. …

New head of finance at Bayer

June 7, 2011
Sales and Marketing appointment, sales and marketing

Bayer has appointed Peter Müller as its new head of finance. Currently head of the corporate finance unit within the …

almirall_daniel_martinez_carretero

Almirall appoints Daniel Martínez Carretero as finance head

June 6, 2011
Sales and Marketing appointment, sales and marketing

Spanish pharma company Almirall has appointed Daniel Martínez Carretero as its chief financial officer. In addition to Finance, Daniel will …

Roche

Roche impresses at ASCO with vemurafenib

June 6, 2011
Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …

GSK and Merck cut vaccine prices

June 6, 2011
Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines

GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …

UK pharma opposes off-label rule change

June 6, 2011
Sales and Marketing off label

Prescribing a drug off-label when a licenced alternative exists increases patient safety risks and threatens the development of new medicines, …

Novartis HQ

Novartis eye drug wins wider European licence

June 6, 2011
Sales and Marketing Lucentis, Novartis

Novartis’ Lucentis has been approved in Europe to treat people suffering from vision loss due to macular oedema secondary to …

Service Insight: Video killed the radio star …

June 6, 2011
Medical Communications Service Insight, digital marketing, social media

SERVICE INSIGHTWhile everyone is going digital, are we forgetting the power of the spoken word? Some days it feels as …

Prime Minister David Cameron at a NHS Future Forum event

NHS reform: after the pause, the rewind?

June 3, 2011
Andrew Lansley, NHS reform

The government’s six-week ‘pause’ in the passage of the controversial Health and Social Care Bill has now come to an …

Health Bill ignores research, says charity

June 3, 2011
Cancer Research UK, NHS, trials

The Health and Social Care Bill has ignored the opportunity to place clinical research at the heart of the NHS, …

BMS and Roche to team up in melanoma

June 3, 2011
Sales and Marketing BMS, Roche, melanoma, oncology

Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …

Tarceva impresses again as it seeks to extend its EU licence

June 3, 2011
NSCLC, Roche, Tarceva

Roche and its partner OSI Pharmaceuticals have released another series of positive results for its lung cancer drug Tarceva as …

UNICEF highlights price differences for vaccines

June 2, 2011
Sales and Marketing Unicef, developing world, vaccines

A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …

Functional excipients driving US market growth

June 2, 2011
Manufacturing and Production API, excipients, functional excipients

Drugmakers are increasingly using more sophisticated excipients and blends in order to defend against generic competition, according to new market …

AstraZeneca to stop paying for international conference trips

June 2, 2011
Medical Communications, Sales and Marketing AstraZeneca, congresses, ethics

AstraZeneca will no longer pay for doctors to attend international conferences. The move is the latest development in the industry’s …

Who is the customer in the new NHS?

June 2, 2011
ABPI, Ben Adams, GP consortia, NHS reform, PCTs

As the structure of the NHS is ripped down and rebuilt, the pharma industry is finding itself working in a …

The Gateway to Local Adoption Series

Latest content